OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-5860617
  • Global Artificial T-Cell Receptors Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: June 2017 | Report Code: HBI-5860617

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Global Artificial T- cell receptors Market is estimated to grow with a CAGR of 44% during forecast period 2016 – 2023. Artificial T cell receptors are produced by combining ecto domain (Ag-recognizing domain) to intracellular portion and trans membrane of a signaling molecule. The global artificial T cell receptors market growth is driven r by following factors:

  • Increasing prevalence of chronic disorders
  • Increasing research and development spending on oncology
  • Rising application of T-cell receptors
  • Increasing incidences of immunological disorders

                                                                                                                                                                                                                                                     

Global artificial T cell receptors market is mainly driven by the increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, Alzheimer’s, Parkinson, diabetes etc.. Cancer is the one of the major disease which is increasing with a huge pace, as per WHO, by the end of 2020 there will be approx. $15 million people who are anticipated to have cancer which is rising by approximately 50%. According to National Cancer Institute, the breast cancer is one of the most common cancer disorders in women across the globe. In 2015, around 2.1 million new breast cancer cases were diagnosed in the globe. Moreover, it is estimated that by the end of 2017, around 252,710 new cases of invasive breast cancer in United States will diagnosed. According to WHO and International Agency for Research on Cancer (IARC) western Europe is having higher rate of breast cancer in the world which is around 95 women on per 100,000 women of all ages. The insufficiency of T cells in the body may result in chronic infections and chronic diseases. Thus, the use of artificial t cell receptors helps to full fill the requirement of t cells in the body. Hence, the growing prevalence of chronic disorders is adding growth in the global artificial T cell market. However, stringent government regulation and long duration of trials are the key factors that are restricting the growth of the global artificial T cell receptors market.

Source: OBRC Analysis.

The global artificial T cell receptors market segments include application and end user. Application segment is further sub segmented into:

  • Assays
  • Drug Discovery and Development
  • Therapeutics
  • Other applications





End –user is further segmented into:

  • Pharmaceutical companies
  • Biotechnology companies
  • Research centers
  • Other end user





The report scope is widely categorized on the basis of its application which include assays, drug discovery and development, therapeutics and other applications.

Geographically, the global artificial Tcell receptors market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is expected to have  the largest market  due to increasing prevalence of chronic disorders such as cancer, cardiovascular disorders in North American region. According to national cancer institute around 1.68 million people are suffering from cancer (new cases) in US. Furthermore, the total number of person diagnosed by cancer is expected to reach to around 19 million by the end of 2023 which were 14.5 million in 2014. Hence, the growing number of patients in US region is one of the key factor driving   North American artificial T cell receptors market. Furthermore, Asia Pacific is expected to be the fastest growing region in global artificial T cell receptors market. The is increasing government support and initiatives for the development of artificial T cell receptors and rise in chronic disorders such as cancer, cardiovascular disorders, Alzheimer, Parkinson, etc. in Asia Pacific region is adding meaningful growth in the market. Furthermore, the rising adoption of cloud based systems is anticipated to create gigantic opportunity in the global artificial T cell receptors market.

The artificial t cell receptors market segmented on the basis of  application which is sub-divided into assays, drug discovery and development, therapeutics and other applications. Drug discovery and development held large market share in terms of revenue in global artificial T cell receptors market in 2016. Furthermore, it is expected that the therapeutics application will experience high CAGR during the forecast period. The growth of therapeutic application is mainly driven by the rising use of artificial T cell receptors for development of therapy specifically for HIV infection. The global market is also segmented on the basis of end-users which is sub-divided into biotechnology companies, pharmaceutical companies, research centers and other end users.

The major market players of the global artificial t-cell receptors market are:

  • ADAPTIVE BIOTECH
  • OXFORD BIOMEDICA
  • PRECISION BIOSCIENCE
  • JUNO THERAPEUTICS
  • THERMO FISHER SCIENTIFIC
  • OTHERS







Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.  

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching. Example; On July 14, 2016, Juno therapeutics has acquired RedoxTherapies. The acquisition allows add adenosine receptors antagonist to its portfolio. The company has made an upfront cash payment of $10 million in cash. Furthermore, in July 2016, kite Pharma has entered into and licensing agreement with the reagents of University of California for the development of technology which enables to advance off the shelf allogenic T cell therapies. Hence, all such strategic initiatives adopted by the companies allows them to sustain in the dynamic market and also helps to increase market share globally.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as acquisition, partnership, etc.
  • Provide in detail the different segments such as by application and end users which are affecting the global artificial T cell receptors market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the artificial T cell receptors market.
  • Provide details analysis of Porters 5 force model and other strategic models.
  • Provide revenues of major players of the market such as Thermo Fisher Scientific, Juno Therapeutics, etc.
  • Provide you various the regulatory policies which are affecting the global artificial T cell receptors market.







How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global artificial T cell receptors market offers the longest chain of market segmentation covering major market segmentation based on applications and end users. The report tracks the major market trends in the global artificial T cell receptors market such as development of new therapy for treatment of HIV infection using artificial T cell receptors and so on.  For each market segments covered in global artificial T cell receptors market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the artificial T cell receptors industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key Findings of the global artificial t-cell receptors market.

  • Development of therapy for HIV infection is adding growth in global artificial T cell receptors market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Increasing research and development on oncology
  • Agreement & acquisition is the key strategy adopted by the various market players of global artificial T cell receptors market.
  • Drug discovery and development is the major segment of application. 

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360 DEGREE INDUSTRY ANALYSIS

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        KEY STRATEGIES & ANALYSIS

2.8.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        INCREASING PREVALENCE OF CHRONIC DISORDERS

3.1.2.        INCREASING RESEARCH AND DEVELOPMENT SPENDING ON ONCOLOGY

3.1.3.        RISING APPLICATION OF T-CELL RECEPTORS

3.1.4.        INCREASING INCIDENCES OF IMMUNOLOGICAL DISORDERS

3.2. MARKET RESTRAINTS

3.2.1.        STRINGENT GOVERNMENT REGULATION

3.2.2.        LONG DURATION OF TRIALS

3.3. MARKET OPPORTUNITIES

3.3.1.        GROWING DEMAND FROM EMERGING COUNTRIES

3.3.2.        DEVELOPMENT OF THERAPY FOR HIV INFECTION

3.4.   MARKET CHALLENGES

3.4.1.        LACK OF SKILLED PROFESSIONAL

3.4.2.        HIGH COST OF TREATMENT

4.       MARKET SEGMENTATION

4.1.                     GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET BY APPLICATION

4.1.1.        MARKET DEFINITION AND SCOPE

4.1.2.        DECISION SUPPORT

4.1.3.        DATABASE & ESTIMATION METHODOLOGY

4.1.4.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.5.         OPPORTUNITY MATRIX

4.1.6.        MARKET SEGMENTATION

4.1.6.1.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN ASSAYS

4.1.6.1.1.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.1.2.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.1.3.        TOP PLAYERS & KEY PRODUCTS

4.1.6.1.4.        KEY CONCLUSIONS

4.1.6.2.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN DRUG DISCOVERY

4.1.6.2.1.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.2.2.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.2.3.        TOP PLAYERS & KEY PRODUCTS

4.1.6.2.4.        KEY CONCLUSIONS

4.1.6.3.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN THERAPEUTIC

4.1.6.3.1.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.3.2.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.3.3.        TOP PLAYERS & KEY PRODUCTS

4.1.6.3.4.        KEY CONCLUSIONS

4.1.6.4.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN OTHER APPLICATIONS

4.1.6.4.1.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.6.4.2.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.6.4.3.        TOP PLAYERS & KEY PRODUCTS

4.1.6.4.4.        KEY CONCLUSIONS

4.2.                     GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET BY END USER

4.2.1.        MARKET DEFINITION AND SCOPE

4.2.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4.         OPPORTUNITY MATRIX

4.2.5.        MARKET SEGMENTATION

4.2.5.1.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS IN PHARMACEUTICAL COMPANIES

4.2.5.1.1.      APPLICATION

4.2.5.1.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5.        KEY CONCLUSIONS

4.2.5.2.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS IN BIOTECHNOLOGY COMPANIES

4.2.5.2.1.      APPLICATION

4.2.5.2.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5.        KEY CONCLUSIONS

4.2.5.3.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS IN RESEARCH CENTRES

4.2.5.3.1.      APPLICATION

4.2.5.3.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5.        KEY CONCLUSIONS

4.2.5.4.                        GLOBAL ARTIFICIAL T-CELL RECEPTORS IN OTHERS

4.2.5.4.1.      APPLICATION

4.2.5.4.2.        ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.4.3.        MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.4.4.        TOP PLAYERS & KEY PRODUCTS

4.2.5.4.5.        KEY CONCLUSIONS

5.       COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1.        LIST OF MERGERS & ACQUISITION

5.1.2.        LIST OF JOINT VENTURES

5.1.3.        LIST OF PRODUCT LAUNCHES

5.1.4.        LIST OF PARTNERSHIPS

6.       GEOGRAPHICAL ANALYSIS

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4.                      GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET BY REGION 2014-2023 ($ MILLION)

6.4.1.      NORTH AMERICA

6.4.1.1.  INDUSTRIAL END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.1.2.  TOP COUNTRY ANALYSIS

6.4.1.2.1.      U.S.

6.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3.   KEY CONCLUSIONS

6.4.1.2.2.      CANADA

6.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3.   KEY CONCLUSIONS

6.4.2.      EUROPE

6.4.2.1.  INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.2.2.  TOP COUNTRY ANALYSIS

6.4.2.2.1.      UK

6.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3.   KEY CONCLUSIONS

6.4.2.2.2.      FRANCE

6.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3.   KEY CONCLUSIONS

6.4.2.2.3.      GERMANY

6.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.3.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3.   KEY CONCLUSIONS

6.4.2.2.4.      SPAIN

6.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.4.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3.   KEY CONCLUSIONS

6.4.2.2.5.      REST OF EUROPE

6.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.2.2.5.2.   TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3.   KEY CONCLUSIONS

6.4.3.      ASIA PACIFIC

6.4.3.1.  INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.3.2.  TOP COUNTRY ANALYSIS

6.4.3.2.1.      CHINA

6.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3.   KEY CONCLUSIONS

6.4.3.2.2.      INDIA

6.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3.   KEY CONCLUSIONS

6.4.3.2.3.      JAPAN

6.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.3.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3.   KEY CONCLUSIONS

6.4.3.2.4.      AUSTRALIA

6.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.4.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3.   KEY CONCLUSIONS

6.4.3.2.5.      REST OF ASIA PACIFIC

6.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.3.2.5.2.   TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3.   KEY CONCLUSIONS

6.4.4.      ROW

6.4.4.1.  INDUSTRY END-USER ANALYSIS 2014-2023 ($ MILLION)

6.4.4.2.  TOP COUNTRY ANALYSIS

6.4.4.2.1.      LATIN AMERICA

6.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.1.2.   TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3.   KEY CONCLUSIONS

6.4.4.2.2.      MIDDLE EAST & AFRICA

6.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.4.2.2.2.   TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3.   KEY CONCLUSIONS

7.       COMPANY PROFILES

7.1. ADAPTIVE BIOTECH

7.1.1.        OVERVIEW

7.1.2.        PRODUCT PORTFOLIO

7.1.3.        KEY INNOVATION SECTOR

7.1.4.        STRATEGIC INITIATIVES

7.1.5.        SCOT ANALYSIS

7.1.6.        STRATEGIC ANALYSIS

7.2. CELL MEDICA

7.2.1.        OVERVIEW

7.2.2.        PRODUCT PORTFOLIO

7.2.3.        KEY INNOVATION SECTOR

7.2.4.        STRATEGIC INITIATIVES

7.2.5.        SCOT ANALYSIS

7.2.6.        STRATEGIC ANALYSIS

7.3. ELLI LILLY

7.3.1.        OVERVIEW

7.3.2.        PRODUCT PORTFOLIO

7.3.3.        KEY INNOVATION SECTOR

7.3.4.        STRATEGIC INITIATIVES

7.3.5.        SCOT ANALYSIS

7.3.6.        STRATEGIC ANALYSIS

7.4. JUNO THERAPEUTICS

7.4.1.        OVERVIEW

7.4.2.        PRODUCT PORTFOLIO

7.4.3.        KEY INNOVATION SECTOR

7.4.4.        STRATEGIC INITIATIVES

7.4.5.        SCOT ANALYSIS

7.4.6.        STRATEGIC ANALYSIS

7.5. KITEPHARMA

7.5.1.        OVERVIEW

7.5.2.        PRODUCT PORTFOLIO

7.5.3.        KEY INNOVATION SECTOR

7.5.4.        STRATEGIC INITIATIVES

7.5.5.        SCOT ANALYSIS

7.5.6.        STRATEGIC ANALYSIS

7.6. LONZA

7.6.1.        OVERVIEW

7.6.2.        PRODUCT PORTFOLIO

7.6.3.        KEY INNOVATION SECTOR

7.6.4.        STRATEGIC INITIATIVES

7.6.5.        SCOT ANALYSIS

7.6.6.        STRATEGIC ANALYSIS

7.7. OXFORD BIOMEDICA

7.7.1.        OVERVIEW

7.7.2.        PRODUCT PORTFOLIO

7.7.3.        KEY INNOVATION SECTOR

7.7.4.        STRATEGIC INITIATIVES

7.7.5.        SCOT ANALYSIS

7.7.6.        STRATEGIC ANALYSIS

7.8. PFIZER

7.8.1.        OVERVIEW

7.8.2.        PRODUCT PORTFOLIO

7.8.3.        KEY INNOVATION SECTOR

7.8.4.        STRATEGIC INITIATIVES

7.8.5.        SCOT ANALYSIS

7.8.6.        STRATEGIC ANALYSIS

7.9. PONTIFAX

7.9.1.        OVERVIEW

7.9.2.        PRODUCT PORTFOLIO

7.9.3.        KEY INNOVATION SECTOR

7.9.4.        STRATEGIC INITIATIVES

7.9.5.        SCOT ANALYSIS

7.9.6.        STRATEGIC ANALYSIS

7.10.                  PRECISION BIOSCIENCE

7.10.1.   OVERVIEW

7.10.2.   PRODUCT PORTFOLIO

7.10.3.   KEY INNOVATION SECTOR

7.10.4.   STRATEGIC INITIATIVES

7.10.5.   SCOT ANALYSIS

7.10.6.   STRATEGIC ANALYSIS

7.11.                  REDMILE GROUP

7.11.1.   OVERVIEW

7.11.2.   PRODUCT PORTFOLIO

7.11.3.   KEY INNOVATION SECTOR

7.11.4.   STRATEGIC INITIATIVES

7.11.5.   SCOT ANALYSIS

7.11.6.   STRATEGIC ANALYSIS

7.12.                  SEEKING ALPHA

7.12.1.   OVERVIEW

7.12.2.   PRODUCT PORTFOLIO

7.12.3.   KEY INNOVATION SECTOR

7.12.4.   STRATEGIC INITIATIVES

7.12.5.   SCOT ANALYSIS

7.12.6.   STRATEGIC ANALYSIS

7.13.                  THERMO FISHER SCIENTIFIC

7.13.1.   OVERVIEW

7.13.2.   PRODUCT PORTFOLIO

7.13.3.   KEY INNOVATION SECTOR

7.13.4.   STRATEGIC INITIATIVES

7.13.5.   SCOT ANALYSIS

7.13.6.   STRATEGIC ANALYSIS

7.14.                  UNUMRX

7.14.1.   OVERVIEW

7.14.2.   PRODUCT PORTFOLIO

7.14.3.   KEY INNOVATION SECTOR

7.14.4.   STRATEGIC INITIATIVES

7.14.5.   SCOT ANALYSIS

7.14.6.   STRATEGIC ANALYSIS

7.15.                  OTHERS

7.15.1.   OVERVIEW

7.15.2.   PRODUCT PORTFOLIO

7.15.3.   KEY INNOVATION SECTOR

7.15.4.   STRATEGIC INITIATIVES

7.15.5.   SCOT ANALYSIS

7.15.6.   STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET BY APPLICATION 2014-2023 ($ MILLION)

2.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN ASSAYS BY GEOGRAPHY 2014-2023 ($ MILLION)

3.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN DRUG DISCOVERY BY GEOGRAPHY 2014-2023 ($ MILLION)

4.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN THERAPEUTIC BY GEOGRAPHY 2014-2023 ($ MILLION)

5.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN OTHER APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)

6.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET BY END USER 2014-2023 ($ MILLION)

7.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN PHARMACEUTICAL COMPANIES BY GEOGRAPHY 2014-2023 ($ MILLION)

8.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN BIOTECHNOLOGY COMPANIES BY GEOGRAPHY 2014-2023 ($ MILLION)

9.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN RESEARCH CENTRES BY GEOGRAPHY 2014-2023 ($ MILLION)

10.   GLOBAL ARTIFICIAL T-CELL RECEPTORS IN OTHERS BY GEOGRAPHY 2014-2023 ($ MILLION)

11.   NORTH AMERICA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

12.   EUROPE ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

13.   ASIA PACIFIC ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

14.   REST OF THE WORLD ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

 

LIST OF FIGURES

1.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN ASSAYS 2014-2023 ($ MILLION)

2.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN DRUG DISCOVERY 2014-2023 ($ MILLION)

3.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN THERAPEUTIC 2014-2023 ($ MILLION)

4.       GLOBAL ARTIFICIAL T-CELL RECEPTORS MARKET IN OTHER APPLICATIONS 2014-2023 ($ MILLION)

5.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN PHARMACEUTICAL COMPANIES 2014-2023 ($ MILLION)

6.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN BIOTECHNOLOGY COMPANIES 2014-2023 ($ MILLION)

7.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN RESEARCH CENTERS 2014-2023 ($ MILLION)

8.       GLOBAL ARTIFICIAL T-CELL RECEPTORS IN OTHERS 2014-2023 ($ MILLION)

9.       UNITED STATES (U.S.) ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

10.   CANADA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

11.   UNITED KINGDOM (UK) ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

12.   FRANCE ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

13.   GERMANY ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

14.   SPAIN ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

15.   ROE ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

16.   INDIA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

17.   CHINA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

18.   JAPAN ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

19.   AUSTRALIA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

20.   ROAPAC ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

21.   LATIN AMERICA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

22.   MENA ARTIFICIAL T-CELL RECEPTORS MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.